Obesity
โ๏ธ Obesity is a chronic, complex condition characterised by excessive accumulation of body fat.
It increases the risk of cardiovascular disease, type 2 diabetes, cancers, and premature mortality.
๐ It results from an interaction of genetic, behavioural, environmental, and metabolic factors.
Understanding its causes, features, diagnostics, and management is essential for effective care.
1๏ธโฃ Causes of Obesity
- ๐งฌ Genetic Factors: Influence metabolism, appetite regulation, and fat storage; certain genes predispose to weight gain.
- ๐ Dietary Habits: High-calorie diets, processed foods, sugary drinks, and fast food drive positive energy balance.
- ๐๏ธ Physical Inactivity: Sedentary lifestyle (desk jobs, technology reliance) reduces energy expenditure.
- ๐ฆ Endocrine Disorders: Hypothyroidism, Cushingโs syndrome, PCOS can contribute to weight gain.
- ๐ Medications: Antidepressants, antipsychotics, corticosteroids, antiepileptics may cause weight gain.
- ๐ง Psychosocial Factors: Stress, depression, anxiety can trigger overeating or binge eating.
- ๐ด Sleep Deprivation: Alters ghrelin/leptin โ โ appetite and caloric intake.
- ๐ท Socioeconomic Factors: Limited access to healthy food, exercise facilities, and healthcare increases risk.
2๏ธโฃ Clinical Features
- ๐ Body Mass Index (BMI):
- Class I: 30โ34.9
- Class II: 35โ39.9
- Class III: โฅ40 (morbid obesity)
- ๐ Waist Circumference: Central obesity >40 in (men) or >35 in (women) โ โ metabolic risk.
- โค๏ธ Comorbidities: Hypertension, type 2 diabetes, dyslipidaemia, NAFLD, OSA, osteoarthritis, cancers (breast, colon).
- ๐ค Physical Symptoms: Fatigue, breathlessness, joint pain, reduced mobility.
- ๐ง Psychological Impact: Depression, low self-esteem, social stigma, isolation.
3๏ธโฃ Diagnostic Evaluation
- โ๏ธ BMI calculation: Weight (kg) รท height (mยฒ); โฅ30 = obese.
- ๐ Waist-to-Hip Ratio: Detects central obesity, stronger link with CVD.
- ๐งช Blood tests:
- ๐งฌ Lipid profile โ dyslipidaemia.
- ๐ฉธ Fasting glucose / HbA1c โ screen for diabetes.
- ๐ฆ TFTs โ rule out hypothyroidism.
- ๐ท LFTs โ assess for NAFLD.
- โก Hormonal assays โ PCOS, Cushingโs.
- ๐ด Sleep Studies: If symptoms suggest obstructive sleep apnoea.
4๏ธโฃ Management โ Multidisciplinary Approach
- ๐ฅฆ Lifestyle Interventions (first-line)
- ๐ Dietary Changes: Calorie deficit diet; โ fruit/veg, lean protein, whole grains; โ sugar, processed foods, saturated fats.
- ๐ Physical Activity: โฅ150 min/week of moderate exercise + resistance training.
- ๐ง Behavioural Therapy: CBT for eating behaviours, stress management, relapse prevention.
- ๐ Pharmacological Therapy
- Orlistat โ reduces fat absorption (GI side effects common).
- GLP-1 agonists (e.g., Liraglutide, Semaglutide) โ appetite suppression + weight loss.
- Phentermine/Topiramate โ appetite suppression (US-licensed).
- Metformin โ useful in diabetes/insulin resistance, modest weight benefit.
- ๐ช Surgical Interventions
- Indications: BMI โฅ40, or โฅ35 with comorbidities, and failure of conservative therapy.
- Procedures:
- Gastric bypass โ reduces intake & absorption.
- Gastric sleeve โ reduces stomach size & appetite hormones.
- Adjustable gastric banding โ restricts stomach capacity.
- Requires lifelong follow-up, nutritional supplementation, and psychological support.
- ๐ค Psychological & Social Support
- Counselling โ addresses body image, mood, emotional eating.
- Support groups โ peer motivation and accountability.
๐ก Teaching Pearl
Obesity is not simply excess weight but a chronic disease.
Effective management requires a holistic, patient-centred, long-term approach addressing lifestyle, medical, and psychological needs.
๐ฏ Even modest weight loss (5โ10% of body weight) leads to significant improvements in metabolic health.